Five Below, Inc. Announces First Quarter Fiscal 2017 Earnings Conference Call
May 18, 2017 20:02 pm UTC| Business
PHILADELPHIA, PA, May 18, 2017 -- Five Below, Inc. (NASDAQ:FIVE), the trend-right, high-quality extreme-value brand for pre-teens, teens and beyond, today announced that its financial results for the first quarter of...
Five Below, Inc. Announces First Quarter Fiscal 2017 Earnings Conference Call
May 18, 2017 20:02 pm UTC| Business
PHILADELPHIA, PA, May 18, 2017 -- Five Below, Inc. (NASDAQ:FIVE), the trend-right, high-quality extreme-value brand for pre-teens, teens and beyond, today announced that its financial results for the first quarter of...
Applied Materials Delivers Record Revenue and Earnings Per Share
May 18, 2017 20:02 pm UTC| Business
Record revenue of $3.55 billion up 45 percent year over yearStrong year-over-year increases in gross margin and operating marginRecord EPS of $0.76 and non-GAAP EPS of $0.79 SANTA CLARA, Calif., May 18, 2017 --...
Applied Materials Delivers Record Revenue and Earnings Per Share
May 18, 2017 20:02 pm UTC| Business
Record revenue of $3.55 billion up 45 percent year over yearStrong year-over-year increases in gross margin and operating marginRecord EPS of $0.76 and non-GAAP EPS of $0.79 SANTA CLARA, Calif., May 18, 2017 --...
Brooks Automation to Present at the B. Riley & Co. 18th Annual Investor Conference
May 18, 2017 20:01 pm UTC| Business
CHELMSFORD, Mass., May 18, 2017 -- Brooks Automation, Inc. (Nasdaq:BRKS) announced today that the company will present at the B. Riley Co. 18th Annual Investor Conference at the Loews Santa Monica Beach Hotel, Santa...
May 18, 2017 20:00 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., May 18, 2017 -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ:GBT) today announced that new data supporting its GBT440 program in sickle cell disease (SCD) will be presented at the upcoming...
Nasdaq Welcomes argenx (Nasdaq: ARGX) to The Nasdaq Stock Market
May 18, 2017 19:56 pm UTC| Business
NEW YORK, May 18, 2017 -- argenx (Nasdaq:ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer,...